Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC46H40ClFN8O10 |
InChIKeyCNOAPBMMLZMAAH-UHFFFAOYSA-N |
CAS Registry2567930-99-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | DE | 28 Sep 2020 |